Welcome! Discover how 3Helix is innovating nAMD research
Welcome to 3Helix! We are a company dedicated to revolutionizing how fibrotic and inflammatory conditions like nAMD are studied and treated. 3Helix accomplishes this through our proprietary Collagen Hybridizing Peptides (CHPs); synthetic peptides which specifically bind to damaged collagen by recognizing its highly conserved 3D structure.
This ability has given nAMD researchers like Dr. Peter Westenskow the ability to confidently determine disease activity and comment on the reversibility of fibrosis. Together, these observations help diagnose conditions, monitor treatment efficacy, and stratify patient populations based on the activity of their disease.
Visit us at Booth #5104 to learn more about our CHP technology and how its applications have already helped fight against fibrotic and inflammatory conditions like nAMD.